Cargando…

The Therapeutic Significance of Mesenchymal Stem Cells in COVID-19 Acute Pulmonary Respiratory Disease

The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome-related coronavirus-2 continues its effects around the world with its new variants. Coronavirus disease 2019 infection may continue with a post-coronavirus disease period, which is characterized by high morbidity apart...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kançağı, Derya Dilek, Ovalı, Ercüment
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Turkish Thoracic Society 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524499/ https://www.ncbi.nlm.nih.gov/pubmed/35943071 http://dx.doi.org/10.5152/TurkThoracJ.2022.21302

Ejemplares similares

Preparation of Cell-Loaded Microbeads as Stable and Injectable Delivery Platforms for Tissue Engineering
por: Karaca, Mehmet Ali, et al.
Publicado: (2023)

The effects of thymoquinone on pancreatic cancer and immune cells
por: Alandağ, Celal, et al.
Publicado: (2022)

In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A
por: Hemşinlioğlu, Cansu, et al.
Publicado: (2023)

Factors Affecting the Population of Mesenchymal Stem Cells in Adipose-Derived Stromal Vascular Fraction
por: Karadağ Sarı, E. Çiğdem, et al.
Publicado: (2022)

microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model
por: Arisan, Elif Damla, et al.
Publicado: (2022)

SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients
por: TAŞTAN, Cihan, et al.
Publicado: (2020)

Mesenchymal Stem Cell Treatment for Steroid Refractory Graft-versus-Host Disease in Children: A Pilot and First Study from Turkey
por: Erbey, Fatih, et al.
Publicado: (2016)

Mutational landscape of SARS-CoV-2 genome in Turkey and impact of mutations on spike protein structure
por: Hatirnaz Ng, Ozden, et al.
Publicado: (2021)

Suprachoroidal spheroidal mesenchymal stem cell implantation in retinitis pigmentosa: clinical results of 6 months follow-up
por: Özkan, Berna, et al.
Publicado: (2023)

Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients
por: Taştan, Cihan, et al.
Publicado: (2020)

Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application
por: Erdoğan, Ebru, et al.
Publicado: (2022)

Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment
por: Wang, Wendi, et al.
Publicado: (2021)

Identifying the Therapeutic Significance of Mesenchymal Stem Cells
por: Mishra, Vineet Kumar, et al.
Publicado: (2020)

CMV-specific T-Cells for Treatment of CMV Infection after Hematopoietic Stem Cell Transplantation in a Pediatric Case: First Application in Turkey
por: Celilova, Sevil, et al.
Publicado: (2020)

Mesenchymal stem/stromal cells: the therapeutic effects in animal models of acute pulmonary diseases
por: Sadeghian Chaleshtori, Sirous, et al.
Publicado: (2020)

Coronavirus-2019 Disease (COVID-19) in Children
por: Ovali, Fahri
Publicado: (2020)

Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome
por: Wang, Yan-Yang, et al.
Publicado: (2013)

Current therapeutic strategies for respiratory diseases using mesenchymal stem cells
por: Wang, Ming‐yao, et al.
Publicado: (2021)

Therapeutic role of mesenchymal stem cell-derived exosomes in respiratory disease
por: Zargar, Mehdi Jahedi, et al.
Publicado: (2022)

Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside
por: Zhang, Lei-Sheng, et al.
Publicado: (2021)

Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure
por: Durand, Nisha, et al.
Publicado: (2020)

Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates
por: Sir Karakus, Gozde, et al.
Publicado: (2021)

Risk Factors and Outcomes of Acute Kidney Injury in Neonates with Persistent Pulmonary Hypertension of the Newborn
por: Ustun, Nuran, et al.
Publicado: (2021)

Mesenchymal stem cell use in acute respiratory distress syndrome: a potential therapeutic application
por: Freitag, Julien, et al.
Publicado: (2020)

Therapeutic Benefits of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome: Potential Mechanisms and Challenges
por: Cao, Chao, et al.
Publicado: (2022)

Chronic Obstructive Pulmonary Disease and Off-Pump Coronary Surgery
por: Ovalı, Cengiz, et al.
Publicado: (2018)

The Effect of Cerebral Oximeter Use on the Shunt Placement Concerning Carotid Endarterectomy Surgery
por: Ceyhan, Dilek, et al.
Publicado: (2019)

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19
por: Iglesias, Martin, et al.
Publicado: (2021)

Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis
por: Yang, Shengnan, et al.
Publicado: (2021)

Mesenchymal Stem Cells Represent a Potential Therapeutic Option for Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome
por: Zhao, Xuan, et al.
Publicado: (2020)

Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease
por: Mohammadipoor, Arezoo, et al.
Publicado: (2018)

Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome
por: Lin, Feng, et al.
Publicado: (2020)

Treatment of Acute Respiratory Distress Syndrome Caused by COVID-19 with Human Umbilical Cord Mesenchymal Stem Cells
por: Bukreieva, Tetiana, et al.
Publicado: (2023)

RUNX1 mediates the therapeutic effects of mesenchymal stem cells‐derived microparticles in acute respiratory distress syndrome
por: Predescu, Dan, et al.
Publicado: (2023)

Mesenchymal Stem/Stromal Cells: SAFETY OF CORD TISSUE DERIVED MESENCHYMAL STROMAL CELLS IN COVID-19 RELATED ACUTE RESPIRATORY DISTRESS SYNDROME
por: Shaz, B., et al.
Publicado: (2022)

Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice
por: Turan, Raife Dilek, et al.
Publicado: (2021)

The rationale of using mesenchymal stem cells in patients with COVID‐19‐related acute respiratory distress syndrome: What to expect
por: Can, Alp, et al.
Publicado: (2020)

Mesenchymal Stem Cells Reconditioned in Their Own Serum Exhibit Augmented Therapeutic Properties in the Setting of Acute Respiratory Distress Syndrome
por: Xu, Amy L., et al.
Publicado: (2019)

Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19
por: Paris, Gustavo C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dskmu3hre01sshhlks7g3chq21